| Application number | Title of the application | Filing Date | Status |
|---|
Array
(
[id] => 641629
[patent_doc_number] => 07122328
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2006-10-17
[patent_title] => 'Gene involved in mineral deposition and uses thereof'
[patent_app_type] => utility
[patent_app_number] => 10/169596
[patent_app_country] => US
[patent_app_date] => 2001-01-05
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 22941
[patent_no_of_claims] => 6
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 25
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/07/122/07122328.pdf
[firstpage_image] =>[orig_patent_app_number] => 10169596
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/169596 | Gene involved in mineral deposition and uses thereof | Jan 4, 2001 | Issued |
Array
(
[id] => 5935449
[patent_doc_number] => 20020061312
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2002-05-23
[patent_title] => 'Innate immune system-directed vaccines'
[patent_app_type] => new
[patent_app_number] => 09/752832
[patent_app_country] => US
[patent_app_date] => 2001-01-03
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 11
[patent_figures_cnt] => 11
[patent_no_of_words] => 18704
[patent_no_of_claims] => 47
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 27
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0061/20020061312.pdf
[firstpage_image] =>[orig_patent_app_number] => 09752832
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/752832 | Innate immune system-directed vaccines | Jan 2, 2001 | Abandoned |
| 09/701121 | MONOMER PROTEIN WITH BONE MORPHOGENETIC ACTIVITY AND MEDICINAL AGENT CONTAINING THE SAME FOR PREVENTING AND TREATING DISEASES OF CARTILAGE AND BONE | Jan 2, 2001 | Abandoned |
Array
(
[id] => 6083017
[patent_doc_number] => 20020082400
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2002-06-27
[patent_title] => 'Conjugates of T cell epitope deficient immunogen analogs for humoral anergy and chemically defined non-polymeric valency platform molecules'
[patent_app_type] => new
[patent_app_number] => 09/753350
[patent_app_country] => US
[patent_app_date] => 2000-12-29
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 17
[patent_figures_cnt] => 17
[patent_no_of_words] => 31115
[patent_no_of_claims] => 21
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 12
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0082/20020082400.pdf
[firstpage_image] =>[orig_patent_app_number] => 09753350
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/753350 | Conjugates of T cell epitope deficient immunogen analogs for humoral anergy and chemically defined non-polymeric valency platform molecules | Dec 28, 2000 | Abandoned |
Array
(
[id] => 6356757
[patent_doc_number] => 20020058040
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2002-05-16
[patent_title] => 'Stable immunogenic composition for frozen storage'
[patent_app_type] => new
[patent_app_number] => 09/747825
[patent_app_country] => US
[patent_app_date] => 2000-12-22
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 14
[patent_figures_cnt] => 14
[patent_no_of_words] => 10453
[patent_no_of_claims] => 34
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 42
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0058/20020058040.pdf
[firstpage_image] =>[orig_patent_app_number] => 09747825
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/747825 | Stable immunogenic composition for frozen storage | Dec 21, 2000 | Abandoned |
Array
(
[id] => 1476697
[patent_doc_number] => 06451311
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2002-09-17
[patent_title] => 'Anti-procalcitonin antibodies and the preparation and use thereof'
[patent_app_type] => B2
[patent_app_number] => 09/742375
[patent_app_country] => US
[patent_app_date] => 2000-12-22
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 1
[patent_figures_cnt] => 1
[patent_no_of_words] => 9366
[patent_no_of_claims] => 11
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 21
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/451/06451311.pdf
[firstpage_image] =>[orig_patent_app_number] => 09742375
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/742375 | Anti-procalcitonin antibodies and the preparation and use thereof | Dec 21, 2000 | Issued |
| 09/803171 | Method for treating rheumatoid arthritis with composition containing histone | Dec 17, 2000 | Abandoned |
Array
(
[id] => 6880451
[patent_doc_number] => 20010031738
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2001-10-18
[patent_title] => 'Methods and pharmaceutical formulations for the treatment of pulmonary hypertension and methods for screening compounds useful in the treatment of pulmonary hypertension'
[patent_app_type] => new
[patent_app_number] => 09/738685
[patent_app_country] => US
[patent_app_date] => 2000-12-15
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 8593
[patent_no_of_claims] => 30
[patent_no_of_ind_claims] => 5
[patent_words_short_claim] => 34
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0031/20010031738.pdf
[firstpage_image] =>[orig_patent_app_number] => 09738685
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/738685 | Methods and pharmaceutical formulations for the treatment of pulmonary hypertension and methods for screening compounds useful in the treatment of pulmonary hypertension | Dec 14, 2000 | Abandoned |
Array
(
[id] => 1324505
[patent_doc_number] => 06599507
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2003-07-29
[patent_title] => 'Composition for the treatment of immune deficiencies and methods for its preparation and use'
[patent_app_type] => B2
[patent_app_number] => 09/738704
[patent_app_country] => US
[patent_app_date] => 2000-12-15
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 7127
[patent_no_of_claims] => 21
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 27
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/599/06599507.pdf
[firstpage_image] =>[orig_patent_app_number] => 09738704
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/738704 | Composition for the treatment of immune deficiencies and methods for its preparation and use | Dec 14, 2000 | Issued |
Array
(
[id] => 6496341
[patent_doc_number] => 20020025323
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2002-02-28
[patent_title] => 'Compositions and methods for enhancing immunogenicity of antigens'
[patent_app_type] => new
[patent_app_number] => 09/735450
[patent_app_country] => US
[patent_app_date] => 2000-12-13
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 6
[patent_figures_cnt] => 6
[patent_no_of_words] => 5337
[patent_no_of_claims] => 12
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 23
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0025/20020025323.pdf
[firstpage_image] =>[orig_patent_app_number] => 09735450
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/735450 | Compositions and methods for enhancing immunogenicity of antigens | Dec 12, 2000 | Issued |
Array
(
[id] => 6279420
[patent_doc_number] => 20020107367
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2002-08-08
[patent_title] => 'Process for isolation and purification of yolk antibodies from avian egg yolk and uses of yolk antibodies obtained thereby'
[patent_app_type] => new
[patent_app_number] => 09/733210
[patent_app_country] => US
[patent_app_date] => 2000-12-08
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 4
[patent_figures_cnt] => 4
[patent_no_of_words] => 6706
[patent_no_of_claims] => 60
[patent_no_of_ind_claims] => 5
[patent_words_short_claim] => 27
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0107/20020107367.pdf
[firstpage_image] =>[orig_patent_app_number] => 09733210
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/733210 | Process for selectively isolating avian immunoglobulins | Dec 7, 2000 | Issued |
Array
(
[id] => 299559
[patent_doc_number] => 07537757
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2009-05-26
[patent_title] => 'Methods of facilitating vascular growth in cardiac muscle and methods for the production of recombinant EMAP II'
[patent_app_type] => utility
[patent_app_number] => 09/733306
[patent_app_country] => US
[patent_app_date] => 2000-12-08
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 4993
[patent_no_of_claims] => 6
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 71
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/07/537/07537757.pdf
[firstpage_image] =>[orig_patent_app_number] => 09733306
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/733306 | Methods of facilitating vascular growth in cardiac muscle and methods for the production of recombinant EMAP II | Dec 7, 2000 | Issued |
| 09/719053 | Acrosomal sperm protein and uses thereof | Dec 6, 2000 | Abandoned |
Array
(
[id] => 6879976
[patent_doc_number] => 20010031262
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2001-10-18
[patent_title] => 'Controlled delivery of antigens'
[patent_app_type] => new
[patent_app_number] => 09/730921
[patent_app_country] => US
[patent_app_date] => 2000-12-06
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 9178
[patent_no_of_claims] => 39
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 63
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0031/20010031262.pdf
[firstpage_image] =>[orig_patent_app_number] => 09730921
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/730921 | Controlled delivery of antigens | Dec 5, 2000 | Abandoned |
Array
(
[id] => 6032078
[patent_doc_number] => 20020018778
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2002-02-14
[patent_title] => 'Passive desensitization'
[patent_app_type] => new
[patent_app_number] => 09/731221
[patent_app_country] => US
[patent_app_date] => 2000-12-06
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 4
[patent_figures_cnt] => 4
[patent_no_of_words] => 15835
[patent_no_of_claims] => 67
[patent_no_of_ind_claims] => 13
[patent_words_short_claim] => 11
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0018/20020018778.pdf
[firstpage_image] =>[orig_patent_app_number] => 09731221
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/731221 | Passive desensitization | Dec 5, 2000 | Abandoned |
Array
(
[id] => 6838470
[patent_doc_number] => 20030035810
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2003-02-20
[patent_title] => 'Microbial delivery system'
[patent_app_type] => new
[patent_app_number] => 09/731375
[patent_app_country] => US
[patent_app_date] => 2000-12-06
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 4
[patent_figures_cnt] => 4
[patent_no_of_words] => 12351
[patent_no_of_claims] => 33
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 23
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0035/20030035810.pdf
[firstpage_image] =>[orig_patent_app_number] => 09731375
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/731375 | Microbial delivery system | Dec 5, 2000 | Issued |
Array
(
[id] => 1073599
[patent_doc_number] => 06838264
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2005-01-04
[patent_title] => 'Antibodies and peptide antigens for producing antibodies having a selective binding specificity to bioactive intact parathyroid hormone (PTH) 1-84'
[patent_app_type] => utility
[patent_app_number] => 09/730174
[patent_app_country] => US
[patent_app_date] => 2000-12-05
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 4
[patent_figures_cnt] => 4
[patent_no_of_words] => 4785
[patent_no_of_claims] => 5
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 174
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/838/06838264.pdf
[firstpage_image] =>[orig_patent_app_number] => 09730174
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/730174 | Antibodies and peptide antigens for producing antibodies having a selective binding specificity to bioactive intact parathyroid hormone (PTH) 1-84 | Dec 4, 2000 | Issued |
Array
(
[id] => 1103815
[patent_doc_number] => 06811782
[patent_country] => US
[patent_kind] => B1
[patent_issue_date] => 2004-11-02
[patent_title] => 'Peptide composition as immunogen for the treatment of allergy'
[patent_app_type] => B1
[patent_app_number] => 09/701623
[patent_app_country] => US
[patent_app_date] => 2000-12-01
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 26711
[patent_no_of_claims] => 4
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 81
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/811/06811782.pdf
[firstpage_image] =>[orig_patent_app_number] => 09701623
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/701623 | Peptide composition as immunogen for the treatment of allergy | Nov 30, 2000 | Issued |
| 09/728404 | Inhibitors of protease-activated receptor-2(PAR-2) as novel asthma therapeutics | Nov 27, 2000 | Abandoned |
| 09/700865 | Vegf activity inhibitors | Nov 19, 2000 | Abandoned |